These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25247946)

  • 1. MRI findings after prostatic artery embolization for treatment of benign hyperplasia.
    Frenk NE; Baroni RH; Carnevale FC; Gonçalves OM; Antunes AA; Srougi M; Cerri GG
    AJR Am J Roentgenol; 2014 Oct; 203(4):813-21. PubMed ID: 25247946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embolization therapy for benign prostatic hyperplasia: influence of embolization particle size on gland perfusion.
    Brook OR; Faintuch S; Brook A; Goldberg SN; Rofsky NM; Lenkinski RE
    J Magn Reson Imaging; 2013 Aug; 38(2):380-7. PubMed ID: 23239260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI features after prostatic artery embolization for the treatment of medium- and large-volume benign hyperplasia.
    Zhang H; Shen Y; Pan J; Wang H; Zhong Y; Wang Y; Ye H
    Radiol Med; 2018 Oct; 123(10):727-734. PubMed ID: 29752646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia.
    Bagla S; Martin CP; van Breda A; Sheridan MJ; Sterling KM; Papadouris D; Rholl KS; Smirniotopoulos JB; van Breda A
    J Vasc Interv Radiol; 2014 Jan; 25(1):47-52. PubMed ID: 24176946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.
    Little MW; Boardman P; Macdonald AC; Taylor N; Macpherson R; Crew J; Tapping CR
    Cardiovasc Intervent Radiol; 2017 May; 40(5):682-689. PubMed ID: 28194505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study.
    de Assis AM; Moreira AM; de Paula Rodrigues VC; Yoshinaga EM; Antunes AA; Harward SH; Srougi M; Carnevale FC
    J Vasc Interv Radiol; 2015 Jan; 26(1):87-93. PubMed ID: 25541446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results.
    Pisco J; Campos Pinheiro L; Bilhim T; Duarte M; Rio Tinto H; Fernandes L; Vaz Santos V; Oliveira AG
    Radiology; 2013 Feb; 266(2):668-77. PubMed ID: 23204546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study.
    Kurbatov D; Russo GI; Lepetukhin A; Dubsky S; Sitkin I; Morgia G; Rozhivanov R; Cimino S; Sansalone S
    Urology; 2014 Aug; 84(2):400-4. PubMed ID: 24929948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Clinical Trial of Balloon Occlusion versus Conventional Microcatheter Prostatic Artery Embolization for Benign Prostatic Hyperplasia.
    Bilhim T; Costa NV; Torres D; Pisco J; Carmo S; Oliveira AG
    J Vasc Interv Radiol; 2019 Nov; 30(11):1798-1806. PubMed ID: 31587950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thickness-to-Height Ratio of Intravesical Prostatic Protrusion Predicts the Clinical Outcome and Morbidity of Prostatic Artery Embolization for Benign Prostatic Hyperplasia.
    Yu SCH; Cho CCM; Hung EHY; Zou J; Yuen BTY; Shi L; Chiu PKF; Yee SCH; Ng ACF
    J Vasc Interv Radiol; 2019 Nov; 30(11):1807-1816. PubMed ID: 31587946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.
    deSouza NM; Flynn RJ; Coutts GA; Gilderdale DJ; Hall AS; Puni R; Chui M; Harris DN; Kiely EA
    AJR Am J Roentgenol; 1995 Jun; 164(6):1429-34. PubMed ID: 7538727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia.
    Camara-Lopes G; Mattedi R; Antunes AA; Carnevale FC; Cerri GG; Srougi M; Alves VA; Leite KR
    Int Braz J Urol; 2013; 39(2):222-7. PubMed ID: 23683668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI assessment of prostatic ischaemia: best predictor of clinical success after prostatic artery embolisation for benign prostatic hyperplasia.
    Kisilevzky N; Faintuch S
    Clin Radiol; 2016 Sep; 71(9):876-82. PubMed ID: 27296474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging for evaluation of uterine arterial embolization of fibroids.
    Faye N; Pellerin O; Thiam R; Chammings F; Brisa M; Marques E; Cuénod CA; Sapoval M; Fournier LS
    Magn Reson Med; 2013 Dec; 70(6):1739-47. PubMed ID: 23440651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Study Using 100-300 Versus 300-500 μm Microspheres for Symptomatic Patients Due to Enlarged-BPH Prostates.
    Gonçalves OM; Carnevale FC; Moreira AM; Antunes AA; Rodrigues VC; Srougi M
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1372-8. PubMed ID: 27509889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE.
    Lin YT; Amouyal G; Correas JM; Pereira H; Pellerin O; Del Giudice C; Déan C; Thiounn N; Sapoval M
    Eur Radiol; 2016 Oct; 26(10):3466-73. PubMed ID: 26738505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "PErFecTED technique": proximal embolization first, then embolize distal for benign prostatic hyperplasia.
    Carnevale FC; Moreira AM; Antunes AA
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1602-5. PubMed ID: 24943914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.